ATYR
Price:
$0.4505
Market Cap:
$44.17M
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis ...[Read more]
Industry
Biotechnology
IPO Date
2015-05-07
Stock Exchange
NASDAQ
Ticker
ATYR
According to aTyr Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -99.87%. This represents a change of 309.71% compared to the average of -24.37% of the last 4 quarters.
The mean historical ROE of aTyr Pharma, Inc. over the last ten years is -78.36%. The current -99.87% ROE has changed 27.45% with respect to the historical average. Over the past ten years (40 quarters), ATYR's ROE was at its highest in in the March 2020 quarter at 4.16%. The ROE was at its lowest in in the September 2025 quarter at -32.09%.
Average
-78.36%
Median
-83.24%
Minimum
-111.41%
Maximum
-30.89%
Discovering the peaks and valleys of aTyr Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.93%
Maximum Annual ROE = -30.89%
Minimum Annual Increase = -53.99%
Minimum Annual ROE = -111.41%
| Year | ROE | Change |
|---|---|---|
| 2025 | -109.84% | 20.12% |
| 2024 | -91.44% | 64.51% |
| 2023 | -55.58% | -12.39% |
| 2022 | -63.44% | 105.35% |
| 2021 | -30.89% | -39.73% |
| 2020 | -51.26% | -53.99% |
| 2019 | -111.41% | 8.62% |
| 2018 | -102.57% | 36.69% |
| 2017 | -75.04% | -18.55% |
| 2016 | -92.12% | 120.93% |
The current ROE of aTyr Pharma, Inc. (ATYR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-85.62%
5-year avg
-70.24%
10-year avg
-78.36%
aTyr Pharma, Inc.’s ROE is greater than ALX Oncology Holdings Inc. (-124.06%), greater than CAMP4 Therapeutics Corporation (-194.74%), less than Quince Therapeutics, Inc. (1.82%), greater than Metagenomi, Inc. Common Stock (-51.23%), greater than Repare Therapeutics Inc. (-57.56%), greater than Unicycive Therapeutics, Inc. (-131.18%), greater than Relmada Therapeutics, Inc. (-71.22%), greater than Acrivon Therapeutics, Inc. Common Stock (-64.43%), greater than MindWalk Holdings Corp. (-63.24%), greater than Precision BioSciences, Inc. (-81.24%),
| Company | ROE | Market cap |
|---|---|---|
| -124.06% | $205.88M | |
| -194.74% | $87.72M | |
| 1.82% | $5.26M | |
| -51.23% | $45.18M | |
| -57.56% | $114.24M | |
| -131.18% | $147.22M | |
| -71.22% | $493.54M | |
| -64.43% | $49.54M | |
| -63.24% | $71.47M | |
| -81.24% | $87.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like aTyr Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like aTyr Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is aTyr Pharma, Inc.'s ROE?
How is the ROE calculated for aTyr Pharma, Inc. (ATYR)?
What is the highest ROE for aTyr Pharma, Inc. (ATYR)?
What is the 3-year average ROE for aTyr Pharma, Inc. (ATYR)?
What is the 5-year average ROE for aTyr Pharma, Inc. (ATYR)?
How does the current ROE for aTyr Pharma, Inc. (ATYR) compare to its historical average?